Incel

Known as: Incel VX-710 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2014
01219982014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The aim of the present study was to evaluate the relationship between handgrip strength and some anthropometric variables in 400… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2011
2011
Hand function requires interaction of muscles, tendons, bones, joints and nerves. The unique construction of the hand provides a… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE The pipecolinate derivative VX-710 (biricodar; Incel) is a clinically applicable modulator of P-glycoprotein (Pgp) and… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2003
2003
Purpose. VX-710 (biricodar, Incel) restores drug sensitivity to cells expressing P-glycoprotein (P-gp) and multidrug resistance… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 2
Is this relevant?
2002
2002
PURPOSE Incel (biricodar, VX-710) restores drug sensitivity to P-glycoprotein (MDR1) and multidrug-resistance-associated protein… (More)
Is this relevant?
2002
2002
PURPOSE VX-710 (biricodar, Incel) restores drug sensitivity to P-glycoprotein (MDR1) and multidrug resistance-associated protein… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE To evaluate the feasibility of administering biricodar (VX-710; Incel, Vertex Pharmaceuticals Inc, Cambridge, MA), an… (More)
Is this relevant?